NNVC (Nanoviricides) Ending Cash Position: $3.21 Mil (As of Mar. 2026)


NNVC Nanoviricides Inc NNVC
35 GF Score
Price $1.51
View Full Analysis

What is Nanoviricides Ending Cash Position?

Nanoviricides NNVC -6.21% 35 Ending Cash Position is $3.21 Mil as of Mar. 2026. GuruFocus rates NNVC with a GF Score™ of 35/100.

Nanoviricides's Ending Cash Position for the quarter that ended in Mar. 2026 was $3.21 Mil.

Nanoviricides's quarterly Ending Cash Position increased from Sep. 2025 ($1.13 Mil) to Dec. 2025 ($5.15 Mil) but then declined from Dec. 2025 ($5.15 Mil) to Mar. 2026 ($3.21 Mil).

Nanoviricides's annual Ending Cash Position declined from Jun. 2023 ($8.15 Mil) to Jun. 2024 ($4.80 Mil) and declined from Jun. 2024 ($4.80 Mil) to Jun. 2025 ($1.56 Mil).


Nanoviricides Ending Cash Position Related Terms


Nanoviricides Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Nanoviricides's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanoviricides Ending Cash Position Chart

Nanoviricides Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.52 14.07 8.15 4.80 1.56

Nanoviricides Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.54 1.56 1.13 5.15 3.21
NNVC
35GF Score
Nanoviricides Inc NNVC
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nanoviricides Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Nanoviricides's Ending Cash Position for the fiscal year that ended in Jun. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=4.799+-3.24
=1.56

Nanoviricides's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=5.151+-1.938
=3.21

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $3.21 Mil mean?
Nanoviricides (NNVC) has a Ending Cash Position of $3.21 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Nanoviricides and its competitors.
Is Nanoviricides' Ending Cash Position too high?
Nanoviricides' current Ending Cash Position is $3.21 Mil. Overall, Nanoviricides has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Nanoviricides' Ending Cash Position compare to LSTA and SGMO?
Nanoviricides' Ending Cash Position of $3.21 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Nanoviricides and its competitors. Nanoviricides's current Ending Cash Position is $3.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanoviricides stock overvalued right now?
Nanoviricides (NNVC) has a current Ending Cash Position of $3.21 Mil. The current Ending Cash Position is $3.21 Mil. Nanoviricides' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Nanoviricides (NNVC), the current Ending Cash Position is $3.21 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nanoviricides Business Description

Other Exchanges NV3P:Germany
Address 1 Controls Drive, Shelton, CT, USA, 06484
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
35GF Score

Get the complete analysis for NNVC

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.51
Price